BioSpace News Archive

National Resilience, Inc. today announced the U.S. Department of Defense (DOD) has awarded Ology Bioservices, Inc. (Ology), a wholly owned subsidiary of Resilience, a contract valued as much as $250 million for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxin.

ChemoCentryx, Inc., announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16th at 5:00 p.m. Eastern Time.

Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres® Y-90 resin microspheres have been approved by the National Medical Products Administration for the treatment of patients with colorectal cancer liver metastases.

Fusion Pharmaceuticals Inc. today announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 12,600 shares.

Evofem Biosciences, Inc., announced today that the U.S. Food and Drug Administration (FDA) has awarded “Qualified Infectious Disease Product” (QIDP) Designation to EVO100 (the investigational name for Phexxi®.

BIONIK Laboratories Corp. today reported financial results for the third quarter and first nine months of fiscal year 2022, ended December 31, 2021.

Selecta Biosciences, Inc. announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the SVB Leerink 11th Annual Global Healthcare Conference, to be held virtually February 14-18, 2022.

Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to combat the rise of antibiotic-resistant infections, announced the completion of a $21M venture equity financing.

BioCryst Pharmaceuticals, Inc. announced that the company will report its fourth quarter and full year 2021 financial results Wednesday, February 23, 2022.